U.S., Oct. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07221747) titled 'PathToScale: The PERSIST Trial' on Oct. 25.
Brief Summary: The purpose of this study is to identify the effectiveness of a bundle of strategies to support continuation of clients on pre-exposure prophylaxis, including long-acting injectable cabotegravir and oral pre-exposure prophylaxis to high priority groups.
Study Start Date: Nov. 01
Study Type: INTERVENTIONAL
Condition:
Oral Pre-exposure Prophylaxis (PrEP)
Long-acting Injectable Cabotegravir for PrEP
Intervention:
BEHAVIORAL: Standard of Care (SoC)
Participants will receive the standard of care per national guidelines of PrEP counseling, national program quality improveme...